P3 Health Partners Inc.
PIII
$2.64
$0.020.76%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -4.66% | -6.16% | -3.93% | 6.87% | 25.58% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -4.66% | -6.16% | -3.93% | 6.87% | 25.58% |
| Cost of Revenue | -7.99% | -3.78% | -2.62% | 11.57% | 43.94% |
| Gross Profit | 38.35% | -68.27% | -81.62% | -89.92% | -535.83% |
| SG&A Expenses | -18.14% | -13.24% | -9.17% | 26.54% | -18.88% |
| Depreciation & Amortization | -2.95% | -2.81% | -2.26% | -2.22% | -0.22% |
| Other Operating Expenses | -230.65% | -75.65% | -796.20% | 1,234.18% | 245.47% |
| Total Operating Expenses | -16.98% | -5.01% | -4.86% | 21.89% | 45.61% |
| Operating Income | 58.67% | -8.90% | 13.10% | -103.00% | -216.35% |
| Income Before Tax | 34.76% | -49.91% | 9.17% | -84.43% | -188.68% |
| Income Tax Expenses | 100.31% | 104.65% | -48.21% | 180.25% | -975.00% |
| Earnings from Continuing Operations | 32.46% | -51.75% | 10.81% | -86.88% | -175.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -32.77% | 39.09% | -23.10% | 61.60% | 134.81% |
| Net Income | 32.09% | -69.40% | -9.52% | -130.21% | -249.82% |
| EBIT | 58.67% | -8.90% | 13.10% | -103.00% | -216.35% |
| EBITDA | 72.82% | -35.27% | 23.58% | -156.40% | -605.16% |
| EPS Basic | 32.71% | -41.66% | 20.11% | -127.68% | -146.75% |
| Normalized Basic EPS | 46.24% | -267.99% | -295.99% | -757.09% | -861.18% |
| EPS Diluted | 38.40% | 15.44% | 20.11% | 3.09% | -163.25% |
| Normalized Diluted EPS | 45.31% | -280.13% | -295.99% | -757.09% | -2,148.58% |
| Average Basic Shares Outstanding | 0.93% | 19.58% | 37.09% | 1.11% | 41.77% |
| Average Diluted Shares Outstanding | -0.79% | 15.77% | 37.09% | 1.11% | -47.33% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |